(NYSE: MDT) is a medical device giant that has generated billions of dollars in earnings over time thanks to its diabetes, cardiovascular, neuroscience, and medical-surgical platforms. The company's growth stagnated in recent years, though, so management set out on a path to transform the business -- with a focus on efficiency and investing in high-growth areas.
However, the medical device leader's share price hasn't yet begun to reflect the company's positive moves. In fact, the stock hasn't done much this year, rising about 1.2%. Considering all this, is Medtronic a buy today, or would it be better to avoid the stock and seek out other opportunities? Motley Fool contributors Adria Cimino and Keith Speights offer their bull and bear cases.
Image source: Getty Images.
Source Fool.com